CSI Market
Sign In | Register

Legend Biotech (LEGN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access LEGN Annual Cash Flow →
Observing cash flow movements over recent quarters helps explain how Legend Biotech adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income-282.60
Depreciation & amortization9.40
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments-168.80
Adjustments For Unrealised Foreign Exchange Losses Gains0.00
Adjustments For Finance Income-
Adjustments For Finance Costs-
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss Trade And Other Receivables-
Gains Losses On Disposals Of Property Plant And Equipment-
Adjustments For Depreciation Of Right Of Use Assets-
Adjustments For Fair Value Gain Loss Of Convertible Redeemable Preferred Shares-
Expense From Sharebased Payment Transactions With Employees-
Deferred Government Grant-
Cash Flows From Used In Operations Before Changes In Working Capital-
Adjustments For Increase Decrease In Trade And Other Payables-
Adjustments For Increase Decrease In Other Operating Payables-
Adjustments For Increase Decrease In Other Non Current Liabilities-
Increase Decrease In Contract Liabilities-
Increase Of Pledged Short Term Deposits Net-
Income Taxes Paid Classified As Operating Activities-
Finance Income Received Classified As Operating Activities-
Interest On Loan From Related Party Classified As Operating Activities-
Income Taxes Paid Refund Classified As Operating Activities-
Interest On Lease Payments Classified As Operating Activities-
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities0.00
Accounts Receivable0.00
Adjustments For Decrease IncreaseIn Trade Account Receivable-5.70
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Other Adjustments To Reconcile Profit Loss1.30
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-130.20
Discontinued operations0.00
Net Cash flow from Operating Activities-100.20
Investing Activities
Capital Expenditures28.60
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans10.80
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net738.20
Discontinued operations0.00
Net Cash Flow from Investing Activities709.60
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net3.30
Other net-615.50
Payments Of Expenses For Issuance Of Convertible Redeemable Preferred Shares-
Increase Decrease In Cash And Cash Equivalents-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.30
Effect of exchange rate on cash flow6.10
Discontinued operations948.60
Free Cash Flow-71.60
Total Cash Flow286.70
4 historic quarters locked

Sign in to unlock the full Legend Biotech cash flow history.

Sign In Create Free Account

About Legend Biotech Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001801198-26-000008

Figures are derived from filed reports and may be restated. Historical data is subject to revision.